ZA200406548B - Process for the preparation of morpholine derivatives and intermediates therefor. - Google Patents

Process for the preparation of morpholine derivatives and intermediates therefor. Download PDF

Info

Publication number
ZA200406548B
ZA200406548B ZA200406548A ZA200406548A ZA200406548B ZA 200406548 B ZA200406548 B ZA 200406548B ZA 200406548 A ZA200406548 A ZA 200406548A ZA 200406548 A ZA200406548 A ZA 200406548A ZA 200406548 B ZA200406548 B ZA 200406548B
Authority
ZA
South Africa
Prior art keywords
formula
alkyl
compound
aryl
heteroaryl
Prior art date
Application number
ZA200406548A
Other languages
English (en)
Inventor
Martin Alistair Hayes
Mark Wilkinson Andrew Jo Mills
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200406548B publication Critical patent/ZA200406548B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200406548A 2002-03-28 2004-08-17 Process for the preparation of morpholine derivatives and intermediates therefor. ZA200406548B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207450.8A GB0207450D0 (en) 2002-03-28 2002-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200406548B true ZA200406548B (en) 2005-09-19

Family

ID=9933999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200406548A ZA200406548B (en) 2002-03-28 2004-08-17 Process for the preparation of morpholine derivatives and intermediates therefor.

Country Status (20)

Country Link
EP (1) EP1487809B1 (de)
JP (1) JP2005532281A (de)
KR (1) KR20050008664A (de)
CN (1) CN1642928A (de)
AR (1) AR039178A1 (de)
AT (1) ATE383349T1 (de)
AU (1) AU2003226760A1 (de)
BR (1) BR0308720A (de)
CA (1) CA2479819A1 (de)
DE (1) DE60318559T2 (de)
ES (1) ES2298539T3 (de)
GB (1) GB0207450D0 (de)
IS (1) IS7401A (de)
MX (1) MXPA04009457A (de)
NO (1) NO20044036L (de)
PL (1) PL373972A1 (de)
RU (1) RU2004125289A (de)
TW (1) TW200401772A (de)
WO (1) WO2003082835A1 (de)
ZA (1) ZA200406548B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
CA2958800C (en) 2014-08-22 2020-10-27 Glaxosmithkline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
US11760701B2 (en) 2018-02-27 2023-09-19 The Research Foundation For The State University Of New Yrok Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2447732A1 (de) * 1974-10-07 1976-04-08 Wuelfing J A Fa Neue morpholinverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA2294453A1 (en) * 1997-06-23 1998-12-30 Fumihiro Hirayama Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
CZ20031194A3 (cs) * 2000-09-29 2003-08-13 Glaxo Group Limited Deriváty močoviny

Also Published As

Publication number Publication date
DE60318559T2 (de) 2009-01-08
AR039178A1 (es) 2005-02-09
ATE383349T1 (de) 2008-01-15
RU2004125289A (ru) 2005-06-27
MXPA04009457A (es) 2005-01-25
IS7401A (is) 2004-08-12
NO20044036L (no) 2004-09-29
KR20050008664A (ko) 2005-01-21
PL373972A1 (en) 2005-09-19
JP2005532281A (ja) 2005-10-27
DE60318559D1 (de) 2008-02-21
EP1487809B1 (de) 2008-01-09
CN1642928A (zh) 2005-07-20
WO2003082835A1 (en) 2003-10-09
ES2298539T3 (es) 2008-05-16
EP1487809A1 (de) 2004-12-22
CA2479819A1 (en) 2003-10-09
BR0308720A (pt) 2005-01-04
GB0207450D0 (en) 2002-05-08
TW200401772A (en) 2004-02-01
AU2003226760A1 (en) 2003-10-13

Similar Documents

Publication Publication Date Title
JP6777398B2 (ja) 薬剤を調製するための方法と中間体
EP2985277B1 (de) Verfahren zur herstellung eines atropisomers eines pyrrol derivats
CA2530159C (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
FR2921657A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique
EP2698367A1 (de) Benzimidazole zur Behandlung von Krebs
JP2020524158A (ja) Ｓｓａｏ阻害剤
MXPA04002653A (es) Metodo para preparar compuestos de pirimidinona y sales farmaceuticamente aceptables del mismo.
CN118047774A (zh) 一种制备非奈利酮及其中间体的方法
US7915427B2 (en) Process for producing aminoacetyl pyrrolidine carbonitrile derivative and intermediate for production thereof
Huang et al. A facile approach to trans-4, 5-pyrrolidine lactam and application in the synthesis of nemonapride and streptopyrrolidine
EP1487809B1 (de) Verfahren zur herstellung von morpholinderivaten und zwischenprodukte dafür
JP2022528690A (ja) （３ｒ，４ｒ）－１－ベンジル－ｎ，４－ジメチルピペリジン－３－アミンまたはその塩の製造方法、およびそれを使用したトファシチニブの製造方法
Nagamine et al. A New Chiral Synthesis of a Bicyclic Enedlone Containing a Seven-Membered Ring Mediated by a Combination of Chiral Amine and Bronsted Acid
AU2006277710A1 (en) Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles
FR2943675A1 (fr) Composes anticancereux, leur preparation et leur application en therapeutique
Chai et al. Urazole synthesis. Part 2: facilitating N4 substitution
Chen et al. Synthesis, Characterization and Suppression of Impurities during Optimization of Dabigatran Etexilate
Xu et al. Impact of atropisomerism on a non-steroidal glucocorticoid receptor agonist
CN122003413A (zh) Jak抑制剂的结晶多晶型物形式a和其制备方法
OA13178A (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors.
Zhang et al. A facile and efficient synthesis of d3‐labelled Reyataz™
FR2943670A1 (fr) Derives anticancereux,leur preparation et leur application en therapeutique
KR20220011669A (ko) Btk 억제제 제조를 위한 방법 및 중간체
WO2025137285A1 (en) Alkyne substituted quinazoline derivatives and uses thereof
JPWO2004058710A1 (ja) 新規ベンズアミド誘導体及びその製造法